Learn more about the role of Tuberculosis in cancer and how a simple vaccine supports the immune system to fight it.

Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...

The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...

Immunotherapy is a type of cancer treatment that helps your immune system detect and fight cancer cells. Treatments may be administered via a catheter, intravenously, or by injection. There are ...

Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly improve patient outcomes for the most common type of bladder cancer, according ...

The following is a summary of “Factors predicting local or systemic side effects related to intravesical BCG (Bacillus Calmette-Guérin) therapy: a retrospective observational study,” published in the ...

Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive ...

A propensity-score matched cohort study found a significantly reduced risk of recurrence of bladder cancer in patients who ...

Discover how AI-based assays offer a promising approach to tailor treatment for high-risk non-muscle-invasive bladder cancer.

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle ...